Vendredi, 17 Novembre 2017
Dernières nouvelles
Principale » FDA approves first-ever med with digital tracking system

FDA approves first-ever med with digital tracking system

15 Novembre 2017

United States regulators have approved the first pill that can be digitally tracked through the body.

For the record, the newly developed Abilify MyCite will not able to track real-time medicine ingestion, but this technology is likely to revolutionize healthcare infrastructure with more and more advancements in the field of digital technology.

The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch". Patients can allow their caregivers and physician to access the information through a web-based portal.

"We need to ensure right from the start of such innovations that there is clear evidence of their benefit and of safeguards against abuses, such as potential for adverse patient reactions, and the risk of invasion of patient privacy", she said.

Mitchell Mathis, from the FDA Centre for Drug Evaluation and Research, said whether the digital pill would increase patient compliance with medication had not been studied.

New Duster SUV revealed in Renault form
For example, the three round air vents have been replaced by two more traditional-looking ones with an octagonal shape. With a ground-clearance of 210mm, the Duster is likely to remain among the best off-roaders in the compact class.

The U.S. Food and Drug Administration (FDA) has reportedly approved a pill that is endowed with a unique digital tracking device.

In Australia, Abilify is used to treat symptoms of schizophrenia and mania in bipolar disorder.

The permit has been granted to Abilify MyCite's Japanese maker Otsuka Pharmaceutical, while the sensor technology and patch are made by Californian medical technology business Proteus Digital Health.

"Consumers already manage important tasks like banking, shopping and communicating with friends and family as they go about their daily lives", he said.

"This technology can help enable individuals with serious mental illness to engage with their care team about their treatment plan in a new way".

FDA approves first-ever med with digital tracking system